Everyone is so concerned with the likes of Pfizer (PFE), Johnson&Johnson (JNJ), Novartis (NVS ... He took a large stake in Celator (CPXX) which had a focus on …
It was a happening week for pharma stocks, Key developments this week included a new CAR-T deal for Pfizer PFE, successful study results from Pfizer, Lilly LLY and Allergan AGN and positive regulatory updates from AstraZeneca …
It is no secret that investors love stock buyback and dividend announcements. Within reason, companies raising dividends and increasing buybacks are particularly loved. Pfizer Inc. (NYSE: PFE) wants its part of the dividend hike and stock …
This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether PFE’s current trading price of $35.38 reflective of the actual value of the large-cap?
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) reported fourth-quarter earnings Tuesday morning, marginally exceeding earnings expectations and meeting expected revenue numbers. And despite issuing better-than-predicted 2018 …
The Dow experienced a mixed week, losing momentum over the first few days before rebounding over the next two. Bond yields spiked following improved inflation and rate hike prospects leading investors to switch from equities to bonds. …